Skip to main content
. 2021 Dec 20;30:100834. doi: 10.1016/j.ymgmr.2021.100834

Table 1.

Characteristics of patients with citrin deficiency and controls.

Patients (n = 10) Controls (n = 35) P-value
Male/female 5/5 20/15
Gestational age (weeks) 39 ± 1.2 39 ± 1.2
Birth weight (g) 2671 ± 237 3037 ± 409 0.0021
Neonatal jaundice 0/10 6/35
Newborn screening
 High citrulline 5 2
 High galactose and citrulline 2 0
 High galactose 1 25
 High galactose-1-phosphate 0 6
 High phenylalanine 2 2
At first visits to our hospital
 Age (days) 20.5 ± 13.6 19.9 ± 13.2
 Serum BUN (mg/dL) 14.4 ± 2.4 (n = 9) 8.7 ± 2.6 (n = 35) <0.001
 Serum creatinine (mg/dL) 0.27 ± 0.06 (n = 9) 0.25 ± 0.07 (n = 35) 0.308
 Serum BUN/creatinine ratio 54.8 ± 13.0 (n = 9) 38.6 ± 16.5 (n = 35) 0.009
 Blood galactose (mg/dL) 18.4 ± 27.1 (n = 8) 1.9 ± 3.8 (n = 31) 0.152
 Plasma citrulline (μM) 668.4 ± 390.6 (n = 10) 39.3 ± 26.7 (n = 18) <0.001
 Plasma phenylalanine (μM) 159.0 ± 227.0 (n = 10) 76.3 ± 38.1 (n = 18) 0.306
 Plasma methionine (μM) 190.6 ± 188.1 (n = 10) 39.6 ± 8.9 (n = 18) 0.0394
 Plasma threonine/serine ratio 3.78 ± 1.75 (n = 10) 1.24 ± 0.66 (n = 17) 0.0017

Data represent mean ± SD.

Each laboratory value of the patient is described in Supplemental Table. BUN, blood urea nitrogen.